Clinical Trial Update: A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease

View source ↗

Summary

A completed Genentech-sponsored study assessing the variability of the 6-minute walk test in cystic fibrosis patients with advanced lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Genentech, Inc. | Conditions: Cystic Fibrosis | Status: COMPLETED